Home / University / University Hospitals / Department of Internal Medicine / Publications
Department of Internal Medicine

Publications

  1. 2019

    • Journal Article

      • Berger, R., Hulsmann, M., Moertl, D. & Polzl, G., 2019. Curriculum heart failure : Task force curriculum heart failure of the working group on heart failure of the Austrian Cardiological Society. Wiener klinische Wochenschrift, 131, S.299-312.

      • Chari, A., Vogl, D.T., Gavriatopoulou, M., Nooka, A.K., Yee, A.J., Huff, C.A., Moreau, P., Dingli, D., Cole, C., Lonial, S., Dimopoulos, M., A. Stewart, K., Richter, J., Vij, R., Tuchman, S., Raab, M.S., Weisel, K.C., Delforge, M., Cornell, R.F., Kaminetzky, D., Hoffman, J.E., Costa, L.J., Parker, T.L., Levy, M., Schreder, M., Meuleman, N., Frenzel, L., Mohty, M., Choquet, S., Schiller, G., Comenzo, R.L., Engelhardt, M., Illmer, T., Vlummens, P., Doyen, C., Facon, T., Karlin, L., Perrot, A., Podar, K., Kauffman, M.G., Shacham, S., Li, L., Tang, S., Picklesimer, C., Saint-Martin, J.-R., Crochiere, M., Chang, H., Parekh, S., Landesman, Y., Shah, J., Richardson, P.G. & Jagannath, S., 2019. Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma. The New England journal of medicine, 381, S.727-738.

      • Egle, A., Melchardt, T., Obrtlikova, P., Smolej, L., Kozak, T., Steurer, M., Andel, J., Burgstaller, S., Mikuskova, E., Gercheva, L., Nosslinger, T., Papajik, T., Ladicka, M., Girschikofsky, M., Hrubisko, M., Jager, U., Voskova, D., Pecherstorfer, M., Kralikova, E., Burcoveanu, C., Spasov, E., Petzer, A., Mihaylov, G., Raynov, J., Oexle, H., Zabernigg, A., Flochova, E., Palasthy, S., Stehlikova, O., Doubek, M., Altenhofer, P., Weiss, L., Magnes, T., Pleyer, L., Klingler, A., Mayer, J. & Greil, R., 2019. Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL-8a mabtenance trial. Cancer medicine, 8, S.1401-1405.

      • Flamm, S., K. Reddy, R., Zadeikis, N., Hassanein, T., Bacon, B.R., Maieron, A., Zeuzem, S., Bourliere, M., Calleja, J.L., Kosloski, M.P., Oberoi, R.K., Lin, C.-W., Yu, Y., Lovell, S., Semizarov, D. & Mensa, F.J., 2019. Efficacy and Pharmacokinetics of Glecaprevir and Pibrentasvir With Concurrent Use of Acid-Reducing Agents in Patients With Chronic HCV Infection. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 17, S.527-535 e6.

      • Gabler, M., Ohrenberger, G. & Funk, G.-C., 2019. Treatment decisions in end-stage COPD: who decides how? A cross-sectional survey of different medical specialties. ERJ open research, 5.

      • Hackner, K., Errhalt, P. & Handzhiev, S., 2019. Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion. Therapeutic advances in medical oncology, 11, S.1758835919850341.

      • Kink, E., Erler, L., Fritz, W., Funk, G.-C., Gabler, M., Krenn, F., Kuhteubl, G., Schindler, O. & Wanke, T., 2019. [Beatmung bei COPD]. Wiener klinische Wochenschrift, 131, S.417-427.

      • Kussmann, M., Ferth, A., Obermuller, M., Pichler, P., Zeitlinger, M., Wiesholzer, M., Burgmann, H., Poeppl, W. & Reznicek, G., 2019. Compatibility of ciprofloxacin with commercial peritoneal dialysis solutions. Scientific reports, 9, S.6512.

      • Li, S., Vallet, S., Sacco, A., Roccaro, A., Lentzsch, S. & Podar, K., 2019. Targeting transcription factors in multiple myeloma: evolving therapeutic strategies. Expert opinion on investigational drugs, 28, S.445-462.

      • Lind, J., Czernilofsky, F., Vallet, S. & Podar, K., 2019. Emerging protein kinase inhibitors for the treatment of multiple myeloma. Expert opinion on emerging drugs, 24, S.133-152.

      • Monino-Romero, S., Lexmond, W.S., Singer, J., Bannert, C., Amoah, A.S., Yazdanbakhsh, M., Boakye, D.A., Jensen-Jarolim, E., Fiebiger, E. & Szepfalusi, Z., 2019. Soluble FcvarepsilonRI: A biomarker for IgE-mediated diseases. Allergy, 74, S.1381-1384.

      • Odeneg, T., Ebner, C., Moertl, D., Keller, H., Dirninger, A., Stix, G., Foger, B., Grimm, G., Steinwender, C., Gebetsberger, F., Stuhlinger, M., Mastnak, B., Haider, C., Manninger, M. & Scherr, D., 2019. Indications for and outcome in patients with the wearable cardioverter-defibrillator in a nurse-based training programme: results of the Austrian WCD Registry. European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology, 18, S.75-83.

      • Senoner, T., Barbieri, F., Semmler, G., Adukauskaite, A., Rubatscher, A., Schgor, W., Stuhlinger, M., Bauer, A., Pfeifer, B.Erich, Fiedler, L., Roithinger, F.Xaver, Hintringer, F., Suessenbacher, A., Wollmann, C.Georg & Dichtl, W., 2019. Long-term performance of an atrial lead capable of accelerometer based detection of cardiac contractility in patients receiving cardiac resynchronisation therapy. PloS one, 14, S.e0222269.

      • Singer, J., Achatz-Straussberger, G., Bentley-Lukschal, A., Fazekas-Singer, J., Achatz, G., Karagiannis, S.N. & Jensen-Jarolim, E., 2019. AllergoOncology: High innate IgE levels are decisive for the survival of cancer-bearing mice. The World Allergy Organization journal, 12, S.100044.

      • Vallet, S., Fan, F., Malvestiti, S., Pecherstorfer, M., Sattler, M., Schneeweiss, A., Schulze-Bergkamen, H., Opferman, J.T., Cardone, M.H., Jager, D. & Podar, K., 2019. Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer. Breast cancer research and treatment, 173, S.585-596.

      • Wagner, G., Steiner, S., Gartlehner, G., Arfsten, H., Wildner, B., Mayr, H. & Moertl, D., 2019. Comparison of transcatheter aortic valve implantation with other approaches to treat aortic valve stenosis: a systematic review and meta-analysis. Systematic reviews, 8, S.44.

    • Conference Paper

      • Grech, C., Hackner, K., Buder, A., Strieder, M., Hochmair, M.J., Filipits, M. & Errhalt, P., 2019. Analysis of circulating tumor DNA in paired plasma and sputum samples of EGFR-mutated NSCLC patients. In European society for medical oncology. European society for medical oncology. Barcelona.

      • Hackner, K., Javaheri, S., Gerges, C., Kneussl, M.P., Errhalt, P., Gerges, M., Maurer, M. & Lang, I.M., 2019. Sleep-Disordered Breathing and Hypoxemia in Treatment-Naïve Patients with Chronic Thromboembolic Pulmonary Hypertension. In American Thoracic Society. American Thoracic Society. Dallas, S. A1994.

      • Lind, J., Czernilofsky, F., Vallet, S., Fan, F., Bakiri, L., Wagner, E.F., Sattler, M., Pecherstorfer, M. & Podar, K., 2019. Combined targeting of distinct c-Myc and JunB transcriptional programs for multiple myeloma therapy. In 17th International Myeloma Workshop. 17th International Myeloma Workshop. Boston, S. 165.

      • Podar, K., 2019. Multiples Myelom II. In DGHO, OeGHO, SGMO & SGH 2019 (Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie). DGHO, OeGHO, SGMO & SGH 2019 (Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie). Berlin.

      • Podar, K., 2019. Transcription factors in multiple myeloma: new potential targets. In 4th Multiple Myeloma and related malignancies. 4th Multiple Myeloma and related malignancies. Bari, Italy.

  2. 2018

    • Journal Article

      • Balber, T., Singer, J., Berroteran-Infante, N., Dumanic, M., Fetty, L., Fazekas-Singer, J., Vraka, C., Nics, L., Bergmann, M., Pallitsch, K., Spreitzer, H., Wadsak, W., Hacker, M., Jensen-Jarolim, E., Viernstein, H. & Mitterhauser, M., 2018. Preclinical In Vitro and In Vivo Evaluation of [(18)F]FE@SUPPY for Cancer PET Imaging: Limitations of a Xenograft Model for Colorectal Cancer. Contrast Media & Molecular Imaging, 2018, S.1269830.

      • Beinhardt, S., Al-Zoairy, R., Kozbial, K., Stattermayer, A.F., Maieron, A., Stauber, R., Strasser, M., Zoller, H., Graziadei, I., Rasoul-Rockenschaub, S., Trauner, M., Ferenci, P. & Hofer, H., 2018. Long-term follow-up of ribavirin-free DAA-based treatment in HCV recurrence after orthotopic liver transplantation. Liver International, 38, S.1188-1197.

      • Breitkreutz, I., Podar, K., Figueroa-Vazquez, V., Wilhelm, S., Hayden, P.J., Anderson, K.C. & Raab, M.S., 2018. The orally available multikinase inhibitor regorafenib (BAY 73-4506) in multiple myeloma. Annals of Hematology, 97, S.839-849.

      • Buder, A., Hochmair, M.J., Schwab, S., Bundalo, T., Schenk, P., Errhalt, P., Mikes, R.E., Absenger, G., Patocka, K., Baumgartner, B., Setinek, U., Burghuber, O.C., Prosch, H., Pirker, R. & Filipits, M., 2018. Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLC. Journal of Thoracic Oncology, 13, S.821-830.

      • Fazekas-Singer, J., Singer, J., Ilieva, K.M., Matz, M., Herrmann, I., Spillner, E., Karagiannis, S.N. & Jensen-Jarolim, E., 2018. AllergoOncology: Generating a canine anticancer IgE against the epidermal growth factor receptor. Journal of Allergy and Clinical Immunology, 142, S.973-976.e11.

      • Hintermair, S., Zwickl-Traxler, E., Pecherstorfer, M. & Singer, J., 2018. Evaluation of vascular events in patients with myeloproliferative syndromes and mutations of either the januskinase-2 or calreticulin gene at the university hospital Krems from 2008 to 2015. Oncotarget, 9, S.8450-8462.

      • Kozbial, K., Moser, S., Al-Zoairy, R., Schwarzer, R., Datz, C., Stauber, R., Laferl, H., Strasser, M., Beinhardt, S., Stattermayer, A.F., Gschwantler, M., Zoller, H., Maieron, A., Graziadei, I., Trauner, M., Steindl-Munda, P., Hofer, H. & Ferenci, P., 2018. Follow-up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin-free treatment. Liver International, 38, S.1028-1035.

      • Krammel, M., Schnaubelt, S., Weidenauer, D., Winnisch, M., Steininger, M., Eichelter, J., Hamp, T., van Tulder, R.Henricus & Sulzgruber, P., 2018. Gender and age-specific aspects of awareness and knowledge in basic life support. PLoS One, 13, S.e0198918.

      • Kreye, G., Masel, E.K., Hackner, K., Stich, B. & Nauck, F., 2018. Methadone as anticancer treatment: hype, hope, or hazard? : A series of case reports and a short review of the current literature and recommendations of the societies. Wiener Medizinische Wochenschrift, 168, S.159-167.

      • Kussmann, M., Hauer, S., Pichler, P., Reznicek, G., Burgmann, H., Poeppl, W., Zeitlinger, M. & Wiesholzer, M., 2018. Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa. European Journal of Clinical Microbiology & Infectious Diseases, 37, S.1091-1098.

      • Masel, E.K. & Kreye, G., 2018. Demystification of palliative care: what palliative care teams don't want you to think about them. memo - Magazine of European Medical Oncology, 11, S.193-195.

      • Neuhold, U., Rohla, M., Glaser, F. & Mihalcz, A., 2018. Eine seltene Rhythmusstörung. Journal für Kardiologie, 25, S.30-33.

      • Odeneg, T., Ebner, C., Moertl, D., Keller, H., Dirninger, A., Stix, G., Foger, B., Grimm, G., Steinwender, C., Gebetsberger, F., Stuhlinger, M., Mastnak, B., Haider, C., Manninger, M. & Scherr, D., 2018. Indications for and outcome in patients with the wearable cardioverter-defibrillator in a nurse-based training programme: results of the Austrian WCD Registry. European Journal of Cardiovascular Nursing , S.1474515118790365.

      • Pirich, T., Zwickl-Traxler, E., Pecherstorfer, M. & Singer, J., 2018. Tolerability of obinutuzumab therapy in patients with rituximab-relapsed/refractory B-cell malignancies - a retrospective single center cohort study. Oncotarget, 9, S.29944-29956.

      • Podar, K., 2018. Choosing an appropriate salvage therapy for a patient with multiple myeloma. Expert Opinion on Pharmacotherapy, 19, S.1511-1516.

      • Poeppl, W., Rainer-Harbach, E., Kussmann, M., Pichler, P., Zeitlinger, M., Wiesholzer, M., Burgmann, H. & Reznicek, G., 2018. Compatibility of linezolid with commercial peritoneal dialysis solutions. American Journal of Health-System Pharmacy, 75, S.1467-1477.

      • Rohla, M., Tscharre, M., Huber, K. & Weiss, T.W., 2018. Lowering blood pressure in primary care in Vienna (LOW-BP-VIENNA) : A cluster-randomized trial. Wiener klinische Wochenschrift, 130, S.698-706.

      • Sponder, M., Khazen, C., Dichtl, W., Fiedler, L., Moertl, D., Teubl, A., Steinwender, C., Martinek, M., Nurnberg, M., Dalos, D., Kastner, J. & Schukro, C., 2018. Specific indications and clinical outcome in patients with subcutaneous implantable cardioverter-defibrillator (ICD) - A nationwide multicentre registry. European Journal of Internal Medicine, 48, S.64-68.

      • Steger, G.G., Dominguez, A., Dobrovolskaya, N., Giotta, F., Tubiana-Mathieu, N., Pecherstorfer, M., Ardizzoia, A., Blasinska-Morawiec, M., Espinosa, E. & Villanova, G., 2018. Single-Agent Oral Vinorelbine as First-Line Chemotherapy for Endocrine-Pretreated Breast Cancer With Bone Metastases and No Visceral Involvement: NORBREAST-228 Phase II Study. Clinical Breast Cancer, 18, S.e41-e47.

      • Strieder, M., Pecherstorfer, M. & Kreye, G., 2018. Symptomatic treatment of dyspnea in advanced cancer patients : A narrative review of the current literature. Wiener Medizinische Wochenschrift, 168, S.333-343.

      • Vallet, S., Fan, F., Malvestiti, S., Pecherstorfer, M., Sattler, M., Schneeweiss, A., Schulze-Bergkamen, H., Opferman, J.T., Cardone, M.H., Jager, D. & Podar, K., 2018. Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer. Breast Cancer Research and Treatment.

      • Vallet, S., Filzmoser, J.M., Pecherstorfer, M. & Podar, K., 2018. Myeloma Bone Disease: Update on Pathogenesis and Novel Treatment Strategies. Pharmaceutics, 10, S.202.

      • Vallet, S., Hoyle, N.R., Kyle, R.A., Podar, K. & Pecherstorfer, M., 2018. A role for bone turnover markers beta-CrossLaps (CTX) and amino-terminal propeptide of type I collagen (PINP) as potential indicators for disease progression from MGUS to multiple myeloma. Leukemia & Lymphoma, 59, S.2431-2438.

      • Vychytil, A., Herzog, R., Probst, P., Ribitsch, W., Lhotta, K., Machold-Fabrizii, V., Wiesholzer, M., Kaufmann, M., Salmhofer, H., Windpessl, M., Rosenkranz, A.R., Oberbauer, R., Konig, F., Kratochwill, K. & Aufricht, C., 2018. A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health. Kidney International.

      • Wurm, R., Schrutka, L., Hammer, A., Moertl, D., Berger, R., Pavo, N., Lang, I.M., Goliasch, G., Huelsmann, M. & Distelmaier, K., 2018. Polyunsaturated fatty acids supplementation impairs anti-oxidant high-density lipoprotein function in heart failure. European Journal of Clinical Investigation, 48, S.e12998.

    • Conference Paper

      • Malvestiti, S., Fan, F., Bashari, H.M., Morelli, E., Seckinger, A., Hose, D., Goldschmidt, H., Zoernig, I., Bakiri, L., Sattler, M., Vallet, S., Pecherstorfer, M., Wagner, E.F., Tassone, P., Jaeger, D. & Podar, K., 2018. Multiple myeloma pathogenesis: The role of JunB in bone marrow angiogenesis. In 23rd Congress of the European Hematology Association (EHA). 23rd Congress of the European Hematology Association (EHA). Stockholm, Sweden.

      • Podar, K., 2018. Multiples Myelom. In 8. Niederösterreichischer Onkologietag. 8. Niederösterreichischer Onkologietag. Krems.

  3. 2017

    • Journal Article

      • Auer, J., Verbrugge, F.H. & Lamm, G., 2017. What do small serum creatinine changes tell us about outcomes after acute myocardial infarction?. European Heart Journal: Acute Cardiovascular Care, S.2048872617728721.

      • Bhanot, H., Weisberg, E.L., Reddy, M.M., Nonami, A., Neuberg, D., Stone, R.M., Podar, K., Salgia, R., Griffin, J.D. & Sattler, M., 2017. Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent metabolic reprogramming. Oncotarget, 8, S.67639-67650.

      • Fan, F., Bashari, M.H., Morelli, E., Tonon, G., Malvestiti, S., Vallet, S., Jarahian, M., Seckinger, A., Hose, D., Bakiri, L., Sun, C., Hu, Y., Ball, C.R., Glimm, H., Sattler, M., Goldschmidt, H., Wagner, E.F., Tassone, P., Jaeger, D. & Podar, K., 2017. The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment. Leukemia, 31, S.1570-1581.

      • Fazekas, J., Grunt, T.W., Jensen-Jarolim, E. & Singer, J., 2017. Long term storage in liquid nitrogen leads to only minor phenotypic and gene expression changes in the mammary carcinoma model cell line BT474. Oncotarget, 8, S.35076-35087.

      • Fazekas-Singer, J., Berroteran-Infante, N., Rami-Mark, C., Dumanic, M., Matz, M., Willmann, M., Andreae, F., Singer, J., Wadsak, W., Mitterhauser, M. & Jensen-Jarolim, E., 2017. Development of a radiolabeled caninized anti-EGFR antibody for comparative oncology trials. Oncotarget, 8, S.83128-83141.

      • Gabler, M., 2017. Cognitive errors in diagnostic decision making - Denkfehler bei diagnostischen Entscheidungen. Wiener Medizinische Wochenschrift, 167, S.333-342.

      • Giustino, G., Redfors, B., Brener, S.J., Kirtane, A.J., Genereux, P., Maehara, A., Dudek, D., Neunteufl, T., Metzger, D.C., Crowley, A., Mehran, R., Gibson, C.M. & Stone, G.W., 2017. Correlates and prognostic impact of new-onset heart failure after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: insights from the INFUSE-AMI trial. European Heart Journal: Acute Cardiovascular Care, S.2048872617719649.

      • Hackner, K. & Pleil, J., 2017. Canine olfaction as an alternative to analytical instruments for disease diagnosis: understanding 'dog personality' to achieve reproducible results. Journal of Breath Research, 11, S.012001.

      • Hackner, K., Errhalt, P. & Doll, T., 2017. Reply to Comment on 'Canine scent detection for the diagnosis of lung cancer in a screening-like situation'. Journal of Breath Research, 11, S.038002.

      • Hackner, K., Riegler, W., Handzhiev, S., Bauer, R., Veres, J., Speiser, M., Meisinger, K. & Errhalt, P., 2017. Fever after bronchoscopy: serum procalcitonin enables early diagnosis of post-interventional bacterial infection. BMC Pulmonary Medicine, 17, S.156.

      • Koller, L., Richter, B., Winter, M.P., Sulzgruber, P., Potolidis, C., Liebhart, F., Moertl, D., Berger, R., Goliasch, G., Lang, I., Wojta, J., Hulsmann, M. & Niessner, A., 2017. Clusterin/apolipoprotein J is independently associated with survival in patients with chronic heart failure. Journal of Clinical Lipidology, 11, S.178-184.

      • Kussmann, M., Baumann, A., Hauer, S., Pichler, P., Zeitlinger, M., Wiesholzer, M., Burgmann, H., Poeppl, W. & Reznicek, G., 2017. Compatibility of fosfomycin with different commercial peritoneal dialysis solutions. European Journal of Clinical Microbiology & Infectious Diseases, 36, S.2237-2242.

      • Lebherz-Eichinger, D., Tudor, B., Ankersmit, H.J., Reiter, T., Haas, M., Einwallner, E., Roth-Walter, F., Krenn, C.G. & Roth, G.A., 2017. Increased trefoil factor 2 levels in patients with chronic kidney disease. PLoS One, 12, S.e0174551.

      • Marek, S., Gamper, G., Reining, G., Bergmann, P., Mayr, H. & Kliegel, A., 2017. ECMO and cytokine removal for bridging to surgery in a patient with ischemic ventricular septal defect - a case report. The International Journal of Artificial Organs, 40, S.526-529.

      • Moertl, D., Altenberger, J., Bauer, N., Berent, R., Berger, R., Böhmer, A., Ebner, C., Fritsch, M., Geyrhofer, F., Huelsmann, M., Poelzl, G. & Stefenelli, T., 2017. Disease management programs in chronic heart failure : Position statement of the Heart Failure Working Group and the Working Group of the Cardiological Assistance and Care Personnel of the Austrian Society of Cardiology. Wiener klinische Wochenschrift, 129, S.869-878.

      • Podar, K. & Jager, D., 2017. Targeting the Immune Niche within the Bone Marrow Microenvironment: The Rise of Immunotherapy in Multiple Myeloma. Current Cancer Drug Targets, 17, S.782-805.

      • Podar, K. & Pecherstorfer, M., 2017. Current and developing synthetic pharmacotherapy for treating relapsed/refractory multiple myeloma. Expert Opinion on Pharmacotherapy, 18, S.1061-1079.

      • Reiberger, T., Puspok, A., Schoder, M., Baumann-Durchschein, F., Bucsics, T., Datz, C., Dolak, W., Ferlitsch, A., Finkenstedt, A., Graziadei, I., Hametner, S., Karnel, F., Krones, E., Maieron, A., Mandorfer, M., Peck-Radosavljevic, M., Rainer, F., Schwabl, P., Stadlbauer, V., Stauber, R., Tilg, H., Trauner, M., Zoller, H., Schofl, R. & Fickert, P., 2017. Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III). Wiener klinische Wochenschrift, 129, S.135-158.

      • Sandhofer, M.J., Robak, O., Frank, H. & Kulnig, J., 2017. Vaccine hesitancy in Austria : A cross-sectional survey. Wiener klinische Wochenschrift, 129, S.59-64.

      • Vallet, S., Pecherstorfer, M. & Podar, K., 2017. Adoptive cell therapy in multiple Myeloma. Expert Opinion on Biological Therapy, 17, S.1511-1522.

      • Wiesholzer, M., Winter, A., Kussmann, M., Zeitlinger, M., Pichler, P., Burgmann, H., Reznicek, G. & Poeppl, W., 2017. Compatibility of Meropenem with Different Commercial Peritoneal Dialysis Solutions. Peritoneal Dialysis International, 37, S.51-55.

      • Worel, N., Fritsch, G., Agis, H., Bohm, A., Engelich, G., Leitner, G.C., Geissler, K., Gleixner, K., Kalhs, P., Buxhofer-Ausch, V., Keil, F., Kopetzky, G., Mayr, V., Rabitsch, W., Reisner, R., Rosskopf, K., Ruckser, R., Zoghlami, C., Zojer, N. & Greinix, H.T., 2017. Plerixafor as preemptive strategy results in high success rates in autologous stem cell mobilization failure. Journal of Clinical Apheresis, 32, S.224-234.

      • Zangrando, M.Maurizio, Böhmer, A. & Glaser, F., 2017. Kardiale Sarkoidose mit Normalisierung einer schwer reduzierten links- und rechtsventrikulären Pumpfunktion. Austrian Journal of Cardiology, 24, S.216-221.

  4. 2016

    • Journal Article

      • Bohn, B., Kerner, W., Seufert, J., Kempe, H.P., Jehle, P.M., Best, F., Fuchtenbusch, M., Knauerhase, A., Hofer, M., Rosenbauer, J. & Holl, R.W., 2016. Trend of antihyperglycaemic therapy and glycaemic control in 184,864 adults with type 1 or 2 diabetes between 2002 and 2014: Analysis of real-life data from the DPV registry from Germany and Austria. Diabetes Research and Clinical Practice, 115, S.31-8.

      • Dalos, D., Gangl, C., Roth, C., Krenn, L., Scherzer, S., Vertesich, M., Lang, I., Maurer, G., Neunteufl, T., Berger, R. & Delle-Karth, G., 2016. Mechanical properties of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent. BMC Cardiovascular Disorders, 16, S.104.

      • Geltner, C., Errhalt, P., Baumgartner, B., Ambrosch, G., Machan, B., Eckmayr, J., Klikovits, T., Hoda, M.Alireza, Popper, H. & Klepetko, W., 2016. Management of malignant pleural mesothelioma – Part 1: epidemiology, diagnosis, and staging. Wiener klinische Wochenschrift, 128, S.611-617.

      • Gennaro, G., Brener, S.J., Redfors, B., Kirtane, A.J., Genereux, P., Maehara, A., Neunteufl, T., Metzger, D.C., Mehran, R., Gibson, C.M. & Stone, G.W., 2016. Effect of Smoking on Infarct Size and Major Adverse Cardiac Events in Patients With Large Anterior ST-Elevation Myocardial Infarction (from the INFUSE-AMI Trial). American Journal of Cardiology, 118, S.1097-1104.

      • Grave, M.S., Sterz, F., Nurnberger, A., Fykatas, S., Gatterbauer, M., Stattermayer, A.F., Zajicek, A., Malzer, R., Sebald, D. & van Tulder, R.Henricus, 2016. Safety and feasibility of the RhinoChill immediate transnasal evaporative cooling device during out-of-hospital cardiopulmonary resuscitation: A single-center, observational study. Medicine, 95, S.e4692.

      • Greil, R., Obrtlikova, P., Smolej, L., Kozak, T., Steurer, M., Andel, J., Burgstaller, S., Mikuskova, E., Gercheva, L., Nosslinger, T., Papajik, T., Ladicka, M., Girschikofsky, M., Hrubisko, M., Jager, U., Fridrik, M., Pecherstorfer, M., Kralikova, E., Burcoveanu, C., Spasov, E., Petzer, A., Mihaylov, G., Raynov, J., Oexle, H., Zabernigg, A., Flochova, E., Palasthy, S., Stehlikova, O., Doubek, M., Altenhofer, P., Pleyer, L., Melchardt, T., Klingler, A., Mayer, J. & Egle, A., 2016. Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial. The Lancet Haematology, 3, S.e317-29.

      • Hackner, K., Errhalt, P., Mueller, M.Rolf, Speiser, M., Marzluf, B.A., Schulheim, A., Schenk, P., Bilek, J. & Doll, T., 2016. Canine scent detection for the diagnosis of lung cancer in a screening-like situation. Journal of Breath Research, 10, S.046003.

      • Hoda, M.A., Klikovits, T., Arns, M., Dieckmann, K., Zochbauer-Muller, S., Geltner, C., Baumgartner, B., Errhalt, P., Machan, B., Pohl, W., Hutter, J., Eckmayr, J., Studnicka, M., Flicker, M., Cerkl, P. & Klepetko, W., 2016. Management of malignant pleural mesothelioma – Part 2: therapeutic approaches : Consensus of the Austrian Mesothelioma Interest Group (AMIG). Wiener klinische Wochenschrift, 128, S.618-26.

      • Kettenbach, J., Mittendorfer, M., Wimmer, I., Mader, M., Taubenschuss, E., Unfried, E. & Heinz, G., 2016. Transgastric biopsy of a submucosal gastric tumour. BJR Case Reports, 2, S.20160009.

      • Klikovits, T., Hoda, M.A., Dong, Y., Arns, M., Baumgartner, B., Errhalt, P., Geltner, C., Machan, B., Pohl, W., Hutter, J., Eckmayr, J., Studnicka, M., Flicker, M., Cerkl, P., Kirchbacher, K. & Klepetko, W., 2016. Management of malignant pleural mesothelioma – Part 3: Data from the Austrian Mesothelioma Interest Group (AMIG) database. Wiener klinische Wochenschrift, 128, S.627-34.

      • Kussmann, M., Schuster, L., Wrenger, S., Pichler, P., Reznicek, G., Burgmann, H., Poeppl, W., Zeitlinger, M. & Wiesholzer, M., 2016. Influence of Different Peritoneal Dialysis Fluids on the In Vitro Activity of Cefepime, Ciprofloxacin, Ertapenem, Meropenem and Tobramycin Against Escherichia Coli. Peritoneal Dialysis International, 36, S.662-668.

      • Lammerich, A., Balcke, P., Bias, P., Mangold, S. & Wiesholzer, M., 2016. Cardiovascular Morbidity and Pure Red Cell Aplasia Associated With Epoetin Theta Therapy in Patients With Chronic Kidney Disease: A Prospective, Noninterventional, Multicenter Cohort Study. Clinical Therapeutics, 38, S.276-287 e4.

      • Moser, M., Wiedemann, D., Kitzwogerer, M. & Frank, H., 2016. Adenocarcinoma of the ampulla of Vater metastasising into the right ventricle. BMJ Case Reports, 2016.

      • Roth, C., Berger, R., Scherzer, S., Krenn, L., Gangl, C., Dalos, D., Delle-Karth, G. & Neunteufl, T., 2016. Comparison of magnetic wire navigation with the conventional wire technique for percutaneous coronary intervention of chronic total occlusions: a randomised, controlled study. Heart and Vessels, 31, S.1266-76.

      • Roth, C., Gangl, C., Dalos, D., Krenn, L., Scherzer, S., Gerken, A., Reinwein, M., Zhang, C., Hagmann, M., Wrba, T., Delle-Karth, G., Neunteufl, T., Maurer, G., Vock, P., Mayr, H., Frey, B. & Berger, R., 2016. Outcome after Elective Percutaneous Coronary Intervention Depends on Age in Patients with Stable Coronary Artery Disease - An Analysis of Relative Survival in a Multicenter Cohort and an OCT Substudy. PLoS One, 11, S.e0154025.

      • Schur, S., Weixler, D., Gabl, C., Kreye, G., Likar, R., Masel, E.K., Mayrhofer, M., Reiner, F., Schmidmayr, B., Kirchheiner, K. & Watzke, H.H., 2016. Sedation at the end of life - a nation-wide study in palliative care units in Austria. BMC Palliative Care, 15, S.50.

      • Wagner, G., Moertl, D., Eckhardt, A., Sagel, U., Wrba, F., Dam, K. & Willinger, B., 2016. Chronic Paracoccidioidomycosis with adrenal involvement mimicking tuberculosis - A case report from Austria. Medical Mycology Case Reports, 14, S.12-16.

      • Wiesholzer, M., Pichler, P., Reznicek, G., Wimmer, M., Kussmann, M., Balcke, P., Burgmann, H., Zeitlinger, M. & Poeppl, W., 2016. An Open, Randomized, Single-Center, Crossover Pharmacokinetic Study of Meropenem after Intraperitoneal and Intravenous Administration in Patients Receiving Automated Peritoneal Dialysis. Antimicrobial Agents and Chemotherapy, 60, S.2790-7.

      • Zwickl, H., Zwickl-Traxler, E. & Pecherstorfer, M., 2016. A single-center retrospective analysis of first-line therapy of multiple myeloma with bendamustine-bortezomib-dexamethasone. Leukemia & Lymphoma, 57, S.2065-70.

  5. 2015

    • Journal Article

      • Duck, A., Pigram, L., Errhalt, P., Ahmed, D. & Chaudhuri, N., 2015. IPF Care: a support program for patients with idiopathic pulmonary fibrosis treated with pirfenidone in Europe. Advances in Therapy, 32, S.87-107.

      • Errhalt, P., 2015. Idiopathische Pulmonale Fibrose - ein Update. Journal für Pneumologie, 3, S.11-17.

      • Geltner, C. & Errhalt, P., 2015. Malignant pleural effusion: pathogenesis, diagnosis, and management. memo - Magazine of European Medical Oncology, 8, S.235-241.

      • Grabner, B., Schramek, D., Mueller, K.M., Moll, H.P., Svinka, J., Hoffmann, T., Bauer, E., Blaas, L., Hruschka, N., Zboray, K., Stiedl, P., Nivarthi, H., Bogner, E., Gruber, W., Mohr, T., Zwick, R.Harun, Kenner, L., Poli, V., Aberger, F., Stoiber, D., Egger, G., Esterbauer, H., Zuber, J., Moriggl, R., Eferl, R., Gyorffy, B., Penninger, J.M., Popper, H. & Casanova, E., 2015. Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis. Nature Communications, 6, S.6285.

      • Kussmann, M., Schuster, L., Zeitlinger, M., Pichler, P., Reznicek, G., Wiesholzer, M., Burgmann, H. & Poeppl, W., 2015. The influence of different peritoneal dialysis fluids on the in vitro activity of ampicillin, daptomycin, and linezolid against Enterococcus faecalis. European Journal of Clinical Microbiology & Infectious Diseases, 34, S.2257-63.

      • Lamprecht, B., Mikes, R., Aigner, K., Auer, W., Bolitschek, J., Errhalt, P., Fazekas, A., Flick, H., Funk, G.-C. & Haider, A., 2015. Abstracts Jahrestagung 2015 der Österreichischen Gesellschaft für Pneumologie. Wiener klinische Wochenschrift, 127, S.803-839.

      • Sandhofer, M.J., Salzer, H. & Kulnig, J., 2015. Foreign body aspiration - Sometimes a tough nut to crack. Respiratory Medicine Case Reports, 15, S.18-9.

      • van Tulder, R.Henricus, Laggner, R., Kienbacher, C., Schmid, B., Zajicek, A., Haidvogel, J., Sebald, D., Laggner, A.N., Herkner, H., Sterz, F. & Eisenburger, P., 2015. The capability of professional- and lay-rescuers to estimate the chest compression-depth target: a short, randomized experiment. Resuscitation, 89, S.137-41.

      • Wimmer, I., Minear, G., Brustbauer, R., Gotzinger, P. & Dam, K., 2015. Pancreatic VIPoma visualized by 68Ga DOTA-NOC PET-CT. Nuklearmedizin, 54, S.N32-3.

      • Wollmann, C.Georg, Gradaus, R., Bocker, D., Fetsch, T., Hintringer, F., Hoh, G., Hatala, R., Podczeck-Schweighofer, A., Kreutzer, U., Kamaryt, P., Hauser, T., Kersten, J.F., Wegscheider, K. & Breithardt, G., 2015. Variations of heart rate variability parameters prior to the onset of ventricular tachyarrhythmia and sinus tachycardia in ICD patients. Results from the heart rate variability analysis with automated ICDs (HAWAI) registry. Physiological Measurement, 36, S.1047-61.

      • Wollmann, C.Georg, Steiner, E., Kleinjung, F. & Mayr, H., 2015. A detailed view on pacemaker lead parameters remotely transmitted after magnetic resonance. Pacing and Clinical Electrophysiology, 38, S.746-57.

  6. 2014

    • Journal Article

      • Erbel, R., Aboyans, V., Boileau, C., Bossone, E., Di Bartolomeo, R., Eggebrecht, H., Evangelista, A., Falk, V., Frank, H., Gaemperli, O., Grabenwoger, M., Haverich, A., Iung, B., Manolis, A.J., Meijboom, F., Nienaber, C.A., Roffi, M., Rousseau, H., Sechtem, U., Sirnes, P.A., von Allmen, R.S. & Vrints, C.J., 2014. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. Polish Heart Journal, 72, S.1169-252.

      • Kopec, G., Moertl, D., Miszalski-Jamka, T., Waligora, M., Tyrka, A., Sarnecka, A. & Podolec, P., 2014. Left ventricular mass is preserved in patients with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome. Heart, Lung and Circulation, 23, S.454-61.

      • Oberndorfer, S., Ungersboeck, K., Moser, W., Riedlberger, U., Marhold, F., Heinz, G., Sedivy, R., Brustbauer, R., Kopetzky, G., Vyhnalik, M. & Balcke, P., 2014. Interdisziplinäre neuroonkologische Betreuung eines Patienten mit sekundärem Gliobalstom. Tumorboard, 3, S.13-16.

      • Poelzl, G., Altenberger, J., Pacher, R., Ebner, C.H., Wieser, M., Winter, A., Fruhwald, F., Dornaus, C., Ehmsen, U., Reiter, S., Steinacher, R., Huelsmann, M., Eder, V., Böhmer, A., Pilgersdorfer, L., Ablasser, K., Keroe, D., Groebner, H., Auer, J., Jakl, G., Hallas, A., Ess, M., Ulmer, H. & Heart, F.Austrian W., 2014. Dose matters! Optimisation of guideline adherence is associated with lower mortality in stable patients with chronic heart failure. International Journal of Cardiology, 175, S.83-9.

      • Schilling, M., Sailer, A.S., Heinz, G. & Kutilek, M., 2014. Intrathoracic perforation of bile duct stents in St.p. liver transplantation - Intrathorakale Perforation von Gallenwegsstents bei St. p. Lebertransplantation. Röfo, 186, S.887-8.

      • Teischinger, L., Plass, C., Mayr, H. & Frey, B., 2014. A wide QRS complex tachycardia: what is the mechanism?. Heart Rhythm, 11, S.1079-81.

      • Troughton, R.W., Frampton, C.M., La Rocca, H.P.Brunner, Pfisterer, M., Eurlings, L.W., Erntell, H., Persson, H., O'Connor, C.M., Moertl, D., Karlstrom, P., Dahlstrom, U., Gaggin, H.K., Januzzi, J.L., Berger, R., Richards, A.M., Pinto, Y.M. & Nicholls, M.G., 2014. Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis. European Heart Journal, 35, S.1559-67.

      • Uitz, E., Bahadori, B., McCarty, M.F. & Moghadasian, M.H., 2014. Practical strategies for modulating foam cell formation and behavior. World Journal of Clinical Cases, 2, S.497-506.

      • Wimmer, I., Hartmann, T., Brustbauer, R., Minear, G. & Dam, K., 2014. Selenium levels in patients with autoimmune thyroiditis and controls in lower Austria. Hormone and Metabolic Research, 46, S.707-9.

      • Woehrer, A., Hackl, M., Waldhor, T., Weis, S., Pichler, J., Olschowski, A., Buchroithner, J., Maier, H., Stockhammer, G., Thome, C., Haybaeck, J., Payer, F., von Campe, G., Kiefer, A., Wurtz, F., Vince, G.H., Sedivy, R., Oberndorfer, S., Marhold, F., Bordihn, K., Stiglbauer, W., Gruber-Mosenbacher, U., Bauer, R., Feichtinger, J., Reiner-Concin, A., Grisold, W., Marosi, C., Preusser, M., Dieckmann, K., Slavc, I., Gatterbauer, B., Widhalm, G., Haberler, C. & Hainfellner, J.A., 2014. Relative survival of patients with non-malignant central nervous system tumours: a descriptive study by the Austrian Brain Tumour Registry. British Journal of Cancer, 110, S.286-96.

      • Wollmann, C.Georg, 2014. Reel syndrome in an ICD with DF4 connector. Herzschrittmachertherapie + Elektrophysiologie, 25, S.206-8.

      • Wollmann, C.Georg, Lawo, T., Kuhlkamp, V., Becker, R., Garutti, C., Jackson, T., Brown, M.L. & Mayr, H., 2014. Implantable defibrillators with enhanced detection algorithms: detection performance and safety results from the PainFree SST study. Pacing and Clinical Electrophysiology, 37, S.1198-209.

      • Zweiker, D., Maier, R., Lamm, G., Maurer, E., Heigert, M., Neunteufl, T., Zeindlhofer, E., Grund, M., Aichinger, J., Huber, K., Schneider, J., Pollak, J., Luha, O. & Zweiker, R., 2014. The Austrian transcatheter aortic valve implantation (TAVI) Registry--3 years' data. International Journal of Cardiology, 177, S.114-6.

Events

  1. 14 Mar

    Open House at KL University - March 2020

    14. March 2020, 10:00 - 14:00
    Karl Landsteiner University, Dr.-Karl-Dorrek-Straße 30,3500 Krems, Trakt Y, Erdgeschoß
  2. 27 Mar

    International Skills Lab Symposium 2020

    27. March 2020, 09:00 - 28. March 2020, 18:00
    Karl Landsteiner Privatuniversität für Gesundheitswissenschaften, Skills Lab, Trakt Y
  3. 16 Nov

    Open House at KL University - November 2019

    16. November 2019, 10:00 - 14:00
    Karl Landsteiner Privatuniversität, Dr.-Karl-Dorrek-Straße 30,3500 Krems, Trakt Y, Erdgeschoß